Pulse lineResearch With Heart Logo

Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.

TitleCoffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.
Publication TypeJournal Article
Year of Publication2018
AuthorsHu EA, Selvin E, Grams ME, Steffen LM, Coresh JJ
Secondary AuthorsRebholz CM
JournalAm J Kidney Dis
Volume72
Issue2
Pagination214-222
Date Published2018 08
ISSN1523-6838
KeywordsAtherosclerosis, Coffee, Cohort Studies, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Incidence, Male, Middle Aged, Prospective Studies, Renal Insufficiency, Chronic, Residence Characteristics, Risk Factors
Abstract

BACKGROUND: Moderate coffee consumption has been suggested to be associated with lower risk for chronic conditions such as diabetes, a major precursor to chronic kidney disease (CKD). However, the association between coffee and CKD has not been fully established. STUDY DESIGN: Prospective cohort study.

SETTING & PARTICIPANTS: 14,209 participants aged 45 to 64 years from the Atherosclerosis Risk in Communities (ARIC) Study.

PREDICTORS: Coffee consumption (cups per day) was assessed at visits 1 (1987-1989) and 3 (1993-1995) using food frequency questionnaires.

OUTCOMES: Incident CKD defined as estimated glomerular filtration rate 

RESULTS: There were 3,845 cases of incident CKD over a median of 24 years of follow-up. Men, whites, current smokers, and participants without comorbid conditions were more likely to consume higher amounts of coffee per day. After adjustment for demographic, clinical, and dietary factors, higher categories of coffee consumption were associated with lower risk for incident CKD compared with those who never consumed coffee (HR for 

LIMITATIONS: Self-reported coffee consumption and observational design.

CONCLUSIONS: Participants who drank higher amounts of coffee had lower risk for incident CKD after adjusting for covariates. Coffee consumers may not be at adverse risk for kidney disease.

DOI10.1053/j.ajkd.2018.01.030
Alternate JournalAm J Kidney Dis
PubMed ID29571833
PubMed Central IDPMC6057809
Grant ListR01 DK089174 / DK / NIDDK NIH HHS / United States
K01 DK107782 / DK / NIDDK NIH HHS / United States
T32 HL007024 / HL / NHLBI NIH HHS / United States
HHSN268201700001I / HL / NHLBI NIH HHS / United States
K24 DK106414 / DK / NIDDK NIH HHS / United States
HHSN268201700004I / HL / NHLBI NIH HHS / United States
HHSN268201000021C / HL / NHLBI NIH HHS / United States
HHSN268201700002I / HL / NHLBI NIH HHS / United States
HHSN268201700005I / HL / NHLBI NIH HHS / United States
HHSN268201700003I / HL / NHLBI NIH HHS / United States